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ABSTRACT 
 
Mononuclear cells present in the blood are responsible for producing the different 
components of the blood as they contain hematopoietic stem cells. They are also found to 
contain mesenchymal stem cells which can be differentiated into cartilage, connective tissue 
and bone tissue. For these reasons, steps had been taken to preserve them for use in tissue 
engineering. Three different techniques of cryopreservation had been carried out for MNCs 
isolated from umbilical cord blood and the viability of each was compared. Here, we 
introduced a new set up for vitrifying cells which proved to be a scalable cryopreserving tool. 
In this set up N2 vapour was used for dispersing the droplets of MNC solution supplied by a 
pump into the liquid nitrogen. N2 not only dispersed the droplets but also pre cooled the 
dispersed droplets before it reached liquid nitrogen. The MNC droplets were collected by cell 
strainers kept in liquid nitrogen it was stored in vapour phase liquid nitrogen (-150
o
C) after 
vitrification, which was later thawed and tested for viability. 
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1.  INTRODUCTION 
 
Cryogenics is that branch in physics that deals with the production of very low temperatures 
and the study of its effect on matter. The temperatures involved with cryogenics should be 
lower than -150°C (-238°F or 120°K) [1]. Cryobiology is the study of different effects of low 
temperature on biological system [1]. Cryopreservation is an aspect of cryobiology that deals 
with different process of storing and preserving biological material by cooling it down to 
cryogenic temperatures [1]. It had been successfully cryopreserved different biological 
material such as Red blood cells, embryo, stem cells, etc. [2,3,4].  In this way, 
cryopreservation will provide continuous source of genetically stable living cells and tissues 
for a variety of purposes, including research and biomedical processes in the near future. 
According to cryobiology, at these low temperatures, all biological activities are stopped. 
This includes the biochemical reaction that may lead to cell death [1]. However, most of the 
cell is made up of water so cells may undergo damage due to freezing i.e., damage due to ice 
formation in the extracellular and intracellular level or damage due to the change in phase 
when approaching room temperature [5,6,7]. In order to prevent this damage, an anti-freeze 
compounds known as cryoprotectant agents (CPA) are used to protect the cells or tissues by 
avoiding or decreasing ice crystal formation [8]. Some of the conventional CPAs are 
glycerol, ethylene glycol (EG) and dimethyl sulfoxide (DMSO). However, cryoprotectants 
can be toxic in different ways, and different studies showed the different toxicity of CPAs for 
different types of cells which will be discuss later.  
 
1.1. Different techniques used for cryopreservation: There are different techniques used in 
cryopreservation. Slow freezing and rapid cooling are the main classification. In slow 
freezing the cooling rate are controlled, usually below 10
o
C/min [9] or kept at constant rate of 
1
o
C with the help of some freezing container like “Mr. Frosty” [10]. Different experiment had 
been performed for cells with the slow freezing process [11]. Although this method was 
considered effective, cryoinjury still occurs as a result of cell shrinkage during cooling and 
warming [12,13], toxicity due to increasing solutes concentration [14,15,16] and intracellular 
ice formation (IIF) [17]. In contrast, vitrification as a method of cryopreservation has 
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provided a means to reduce these cryoinjuries significantly [18,19]. The use of N2 gas to for 
developing micro-droplets was also introduced [2]. This shows significant result over classic 
straw plunging technique [20] of vitrification. 
1.2. Umbilical cord blood:  Human umbilical cord blood proved to be a rich source of 
multipotent stem cells for clinical application in neurodegenerative diseases [23,24]. 
Umbilical cord blood is obtained from the umbilical cord at the time of child birth [21]. The 
plancenta is one of the best sources of stem cells, and as the cord blood is coming from the 
placenta, the cord blood itself is a good source of stem cells [22]. Mononuclear cells (MNCs) 
derived from cord blood mainly comprises of a heterogeneous population of hematopoietic 
stem cells and mesenchymal stem cells [25,26]. This is why MNCs are used in therapy for 
degenerative conditions [25]. 
 
1.3. Objective 
 
 To create a set up for scalable vitrification method for cells suspension and to 
compare its viability with the normal straw plunging method. 
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2.  LITERATURE REVIEW 
 
The main objective of cryopreservation is to increase the viability of cells for each technique 
and each CPA used. Viability rate simply defines the quality of preservation. But viability of 
cells greatly affected by the rate of cooling a well as the toxicity of CPA. Conventional CPAs 
such as glycerol, EG and DMSO may cause different effects on the physiology of human 
being [27]. But these are the long term problems if we relate this to cryoprotectant toxicity in 
cryobiology. A study of mouse blastocysts using six CPAs in 30% (v/v) shows EG to be least 
toxic than DMSO and glycerol [28]. However, for oyster embryos, DMSO is less toxic than 
EG [29]. In different studies, appropriate mixture of these CPA shows significant result. The 
most toxic compound, formamide, when combined with DMSO shows the least toxicity as 
CPA for kidney slices [30]. DMSO considerably reduces formamide toxicity (and apparently 
vice-versa). So, the main aim of cryobiologists is to create a good mixture of CPA with low 
toxicity, low viscosity and good vitrifying capability. 
It is found that unlike polyols (glycerol, EG etc), DMSO toxicity can be reduced by mixing it 
with other CPAs [31]. 
 
Toxicity decrease as: 
Formamide > Ethylene glycol > Propylene glycol > N-methyl formamide 
In the year 1993, mixture of EG and DMSO is used for the vitrification of bovine embryos 
[32]. The mixture show significant result. The similar mixture of CPA was again used for the 
vitrification of blastocyst in the year 2000 [33]. Here the same mixture with a bit of change in 
concentration is used. 
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3.  MATERIALS AND METHODS 
 
Different protocols and methods followed for all the steps involving in the cryopreservation 
on mononuclear cells are: 
3.1. Isolation of mononuclear cells from cord blood 
Collection of blood sample 
Cord blood is collected from blood bag under sterile conditions. 
Isolation of mononuclear cells 
1. The bio-safety cabinet is swap with 70% ethanol. 
2. The unprocessed cord blood is diluted in the ratio 1:1 with phosphate buffered saline 
(PBS). 
3. Carefully, 30 ml of diluted cells are layered on 15 ml of Ficoll-Hypaque (1.077 g/ml 
density) in each 50-ml conical tube without disturbing the Ficoll-Hypaque interface. 
4. It was centrifuged for 20-30 min at 450g at room temperature with the brake set to the 
“off” position. 
5. After centrifugation, a layer of mononuclear cells should be visible on top of the Ficoll-
Hypaque phase, as they have lower density than Ficoll-Hypaque solution as shown in Fig. 
1. 
6. Carefully the mononuclear cellswas harvested from the buffy layer located at the interface 
between the medium and Ficoll using 3-ml plastic Pasteur pipette. 
7. The cells were washed with PBS and recover the cells by centrifugation for 10-15 min at 
300g and room temperature. 
8. The supernatant was discarded, the cell pellet was re-suspended and the cells were counted 
using a haemocytometer. 
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Figure1: Density gradient centrifugation 
 
3.2. Experiment No.1 
 
Cryopreservation using -80°C deep freezer 
Cryoprotectant solution composition:      10% DMSO 
                                15% FBS in DMEM Media 
                                 Add cell suspension such that the final 
concentration of DMSO is 10% (v/v) 
PROCEDURE 
1. Prepare fresh cryoprotectant solution and store at 2°C to 8°C until use 
2. Simultaneously take the Mr. Frosty” freezing container and pour isopropanol in it 
(upto 60% of the height of the wall)  and keep it in -6°C to -8 °C freezer 
3. Take the cell suspension isolated from processed peripheral blood or cord blood (refer 
supplement) and determine the total number of cells using hemacytometer, cell 
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counter and Trypan Blue exclusion. Cell count should not be less than 1x 10
7 
viable
 
cells /ml 
4. Centrifuge the cell suspension at approximately 100–200 g  for 5 - 10 minutes  
5. After centrifugation decant the supernatant without disturbing the cell pellet 
6. To the pellet add pre-cooled cryoprotectant solution, FBS and basal media as per 
requirement  
7. Place 1.0 ml of cell mixture in each cryovial 
8. Lable the cryovials  
9. Rapidly transfer the vials to a precooled (4°C) Nalgene freezing container (containing 
isopropanol), and place immediately in a freezer at –80°C 
10. Freezing is generally carried out overnight 
11. After freezing for appropriate time, remove “ Mr. Frosty” freezing from the -80 °C 
deep freezer and take out the vials containing the frozen cells 
12. Now thaw the cells as per protocol mentioned in 3.4. 
13. Perform cell viability analysis according to protocol in 3.5. 
 
3.3. Experiment No.2 
 
Vitrification by plunging straw containing the solution into Liquid Nitrogen 
Cryoprotectant solution composition:             10% DMSO 
                                                                        10% FBS in DMEM Media 
      20% EG 
      1M sacrose 
                                                                        Add cell suspension such that the final                   
                                                                        concentration of DMSO is 10% (v/v) 
PROCEDURE 
Cell Preparation for vitrification 
1. Prepare fresh vitrification solution, filter it using Syringe filter and store at 2°C to 8°C 
until use. 
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2. Take the cell suspension isolated from processed peripheral blood or cord blood(refer 
supplement) and determine the total number of cells using haemocytometer, cell 
counter and Trypan Blue exclusion. Cell count should not be less than 1x 107 viable 
cells /ml. 
3. Centrifuge the cell suspension at approximately 100–200 g for 5 - 10 minutes. 
4. Decant the supernatant without disturbing the cell pellet. 
5. To the cell pellet add vitrification solution. 
6. Allow MNCs to sit in freezing medium (hypertonic vitrification solution) until they 
reach osmotic equilibrium. 
Loading MNCs into Plastic Straw  
1. Using 1ml syringe load the vitrification solution containing MNC’s into the plastic 
straw. 
2. Label the straw using printed labels attached to either a straw sealing plug or to 
another straw connected with a straw adapter. 
3. Remove the straw from the vitrification solution containing MNC’s, and aspirate 
approximately 0.15 cm of air to create a tiny air bubble within the straw. 
4. Aspirate a single MNC in approximately 0.8 cm of hypertonic vitrification solution 
into the straw. 
5. Remove the straw from the vitrification solution and aspirate approximately 0.15cm 
of air to create a second tiny air bubble within the straw (air bubbles serve to 
physically isolate the MNC within the straw). 
6. Aspirate approximately 9.1 cm of vitrification solution to completely fill the straw, 
being certain to draw in a sufficient volume of vitrification solution to moisten the 
polyvinylchloride (PVC) powder that exists within the cotton plug end of the straw. 
7. The vitrification solution causes the PVC powder to gel and seal that end of the straw. 
8. Seal the other end of the straw with PVC powder, plastic straw sealing plugs, or a heat 
sealer. 
9. Place the straws loaded with vitrification solution and MNC’s into the control rate 
freezer whose temperature has been cooled from ambient temperature to -6°C 
10. Allow the sample to sit at this temperature for at least 2 minutes before proceeding 
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Seeding of the sample 
1. Once the MNC’s have cooled to -6°C, use a pair of tongs supercooled in liquid 
nitrogen (or a cotton-tipped stick immersed in liquid nitrogen) to induce ice crystal 
formation in the vitrification solution inside the straw by touching the tongs (or cotton 
tipped stick) to the column of solution. 
2. The water in the vitrification solution will crystallize in the region exposed to liquid 
nitrogen, and ice crystals will spread to the column of vitrification solution 
immediately surrounding the MNC’s. 
3. Hold MNC’s at seeding temperature for 10 minutes before further cooling. 
4. Cool the MNC’s at a rate of 0.5°C/min down to a temperature of -34°C. This cooling 
rate is important to ensure continued dehydration of the MNC’s 
5. Hold the MNC’s at -34°C for 10 minutes before plunging MNC’s into liquid nitrogen 
(-196°C). 
6. Place cryopreserved MNC’s into an appropriately labelled goblet (filled with liquid 
nitrogen) attached to an appropriately labelled cane, and place the cane into a canister 
of a liquid nitrogen dewar for short- or long-term storage 
After completing the above procedure, thawing is done using the procedure in 3.4 and cells 
are counted to check the viability. 
 
3.4. Thawing and cell recovery 
 
After the cells are stored in liquid nitrogen for a night, the cells are thawed and recovered by 
the following procedure: 
1. Carefully remove the MNCs (or mononuclear cells) vial from Liquid Nitrogen Storage 
Tank. 
2. Rapidly thaw frozen vial of cells in a 37°C water bath, until just a small frozen chunk 
remains in the vial. 
3. Spray vial with 70% ethanol to decontaminate it and transfer it to the sterile tissue culture 
hood. 
4. Aseptically transfer the entire contents of the vial into a 15 ml conical tube using a 5 ml 
pipette. 
5. Rinse the vial with 1 ml of thawing media and transfer it to 15 ml centrifuge tube. 
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6. Slowly, add 4 ml of thawing media drop-wise to cells in the 15ml conical tube. While 
adding the medium, gently move the tube back and forth to mix the cells. (This reduces 
osmotic shock to the cells). 
7. Centrifuge the 15 ml tube with the cell suspension at 200g for 2 minutes at room 
temperature. 
8. Carefully aspirate and discard the supernatant without disturbing the cell pellet. 
9. Re-suspend the cell pellet in pre-warmed thawing media (e.g. 4ml/60 mm dish) using a 5 
ml pipette and gently pipette the cells up and down until cell pellet is fully dispersed.  
10. Now check the cell viability using trypan blue and haemocytometer following the protocol 
mentioned in page no. 15   
11. A viability of greater than 70% is expected, however if the viability is less than 70%, it 
may take longer for the cells to reach confluence. 
12. Now take sufficient amount of pre warmed DMEM and gently pipette the cells up and 
down in it. 
13. Now transfer the above into a culture dish. 
 
3.5. Cell Viability 
 
To test the viability, cells are counted twice, before cooling and after thawed, and are 
compared to see the percentage of cells survived. Following is the procedure for counting the 
number of cells. 
1. To prepare the haemocytometer, the mirror-like polished surface is carefully cleaned with 
lens paper and ethanol 
2. The coverslips (which is thicker than those for conventional microscopy) should also be 
cleaned 
3. Take 200 μl of the cell suspension into a 1.5 ml in the centrifuge tube 
4. Add 300 μl of PBS and 500 μl of 0.4% trypan blue solution to the cell suspension 
(creating a dilution factor of 5) 
5. Mix thoroughly and allow to stand for 5 to 15 minutes 
6. Note: Trypan blue dye is taken up by the cell membrane of dead cells only, however if 
cells are exposed to trypan blue for extended periods of time, viable cells may begin to 
take up dye as well as non-viable cells, thus, try to do cell counts within half an hour after 
dye solution is added 
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7. With a cover-slip in place, use a micro pipette and transfer a small amount of the trypan 
blue-cell suspension to a chamber on the haemocytometer 
8. This is done by carefully touching the edge of the cover-slip with the pipette tip and 
allowing the chamber to fill by capillary action. Do not overfill or underfill the chambers 
9. The counting chamber is then placed on the microscope stage and the counting grid is 
brought into focus at low power 
10. One entire grid on standard haemocytometers with Neubauer rulings can be seen at 50x 
(5x objective) 
11. The main divisions separate the grid into 9 large squares. Each square has a surface area of 
1mm
2
, and the depth of the chamber is 0.1mm. Each square of the haemocytometer (with 
cover slip in place) represents a total volume of 0.1 mm
3
or 10
-4
 cm
3
. Since 1 cm3 =1 ml, 
the subsequent cell concentration per ml can be determined. 
 
Cells per ml = the average count per square x the dilution factor x 10
4
 (count 10 squares) 
 
12. Count all the cells (non-viable cells stain blue, viable cells will remain opaque) in the 
1mm center square and the four corner squares 
13. Refer to diagram above. Keep a separate count of viable and non-viable cells. If greater 
than 25% of cells are non-viable, the culture is not being maintained on the appropriate 
amount of media; re-incubate culture and adjust the volume of media according to the 
confluency of the cells and the appearance of the media 
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14. If there are less than 50 or more than 200 cells per large square, repeat the procedure 
adjusting to an appropriate dilution factor 
15. Repeat the count using the other chamber of the haemocytometer 
 
3.6. Peristaltic pump 
 
For the continuous flow of MNCs and CPA solution, peristaltic pump is used. The flow rate 
of the cell solution is controlled by the revolutions per minute (rpm) of the peristaltic pump. 
Different readings of time taken to complete 20mL for different rpm(s) are noted down 
shown in Table1. According to the table, a graph is plot between time taken and the rpm 
shown in Figure2. The graph represented a curve of rectangular hyperbola. The simple 
formula of rectangular hyperbola, xy=c is used to deduce the formula of rpm dependent flow 
rate. 
Sl. No. rpm  
(x) 
time taken in sec  
(y) 
x*y 
1 5 
 
283 1415 
2 10 
 
137 1370 
3 15 
 
91 1365 
4 20 
 
68 1360 
5 25 
 
55 1375 
 
Table1: Change of time with rpm 
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Figure2: Time vs rpm graph for peristaltic pump 
From the table we can approximate the value of ‘c’ which is always constant for any values 
of ‘x’ and ‘y’. By taking the mean of each values in column number 4 (x*y column) we get 
the approximate value of ‘c’. 
c = (1415+1370+1365+1360+1375)/5 = 1377 ~1370 
Each of the noted time(s) are for 20 mL, so, 
Flow rate = 20/y in mL/sec 
But we need mL/min, so we multiply the whole term by 60, therefore, 
Flow rate (say z) = (20*60)/y in mL/min 
Hence, 
x = c/y  = 1370/(1200/z) = (1370*z)/1200 
Putting the value of z (flow rate required), we can find out the rpm required ‘x’ for the 
required flow rate. 
20 
 
3.7. Experimental design 
 
Figure3: Setup design for the new vitrification technique. 
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A silicon rubber pipe 4.8mm diameter is connected to the peristaltic pump. One end of the 
pipe is kept inside a beaker containing a sample mixture of CPA and MNCs and the other end 
is connected with a hypodermic needle, 22G × 1¼" (0.7 × 30mm), where the ejection of 
sample takes place (Figure4). This needle is inserted through the N2 vapour outlet, which is a 
cone shape plastic opening at the base and the top (0.8mm) as shown in Figure2. N2 vapour 
flows through a plastic pipe connected to a Liquid Nitrogen tank. 
 
 
 
Figure4: N2 vapour outlet (cone-like plastic) for dispersion of droplets coming from 
hypodermic needle. 
 
 
 
 
22 
 
When the pressure developed inside the Liquid Nitrogen tank is 0.5 bar, N2 gas is released 
from the outlet of the tank which is passed through a rubber pipe and finally to the outlet 
(Figure6). The N2 gas coming out of the outlet dispersed the sample solution that is made to 
flow using peristaltic pump through the silicon pipe to the orifice opening, shown in Figure6. 
 
 
Figure5: N2 gas passage from Liquid Nitrogen tank 
 
The connector of the gas outlet of liquid nitrogen tank was not available, so, it was self-
constructed by aluminium pipe bought from local hardware store. All the connections were 
sealed by polytetrafluoroethylene (PTFE) also known as thread seal tape (from local 
hardware store).  
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4.  RESULTS AND DISCUSSION 
4.1. Vitrifiction using plunging method 
 
Before vetrifying the sample prepared in 3.3, cells were counted using trypan blue and 
haemocytometer. The cell count was 1.2x10
7
cells/ml. After vetrification was done following 
section 3.3 in Experiment no 2, the cell were thawed using the procedure in section 3.4, and 
the cells were counted as in section 3.5. Viable cells were counted to be around 
0.8x10
7
calls/ml. This is approximately around 67% viability. 
 
4.2. Vitrification using N2 vapour gas 
 
Using the formula given in the section 3.6, 
x = (1370*z)/1200 
we varied the different values of flow rate in ml/min (z) and find the necessary rpm to be set 
on the peristaltic pump. Table2 shows the different rpm used for optimum flow rate. 
 
flow rate in 
ml/min  
(z) 
rpm required 
(x) 
 
5 5.7 
2.5 2.8 
0.5 0.6 
 
Table2: flow rate into rpm 
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This different flow rates were tested. A solution was prepared with 10% DMSO (v/v), 3% 
trypan blue (v/v) and water that made up rest of the volume. This solution had almost similar 
density with cells and CPAs solution. The solution prepared was made to disperse over 
Fabriano handmade-paper (9.5” X 12.5”, 300g/m2), using N2 vapour maintained at 0.5 bar 
pressure. 
 
Figure6: Flow rate of 5ml/min. 
In Figure6, we can see that droplets forme over the paper are big, and dispersion effect of N2 
gas is not that effective. 
25 
 
 
Figure7: Flow rate of 2.5ml/min. 
In Figure7, almost the same effect was seen, so the pressure of N2 gas was increased further 
to 0.8bar and the flow rate of sample was also decreased to 0.5ml/min. 
26 
 
 
Figure8: Flow rate of 0.5ml/min and 0.8bar pressure for N2 gas. 
 
After these changes, from Figure8, we can see the effective disperse effect of N2 vapour gas 
over the paper. As we cn see, the droplets were evn more dispersed, which results in smaller 
size of droplets, till 1mm-3mm in diameter (shown in Figure10). 
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Figure9: 3x zoom of the significant result using Sony Cyber-shot  
 
So, finally the cell samples were prepared by mixing cells suspended in DMEM, 10% 
DMSO, 20% EG and 1M sacrose. A drop of cell suspension was taken and dyed with trypan 
blue and was counted using haemocytometer like in section 3.5. The cell counted showed 
1.8x10
7
cells/ml. the vitrification process was carried out using flow rate 0.5ml/min and N2 
gas pressure 0.8bar. After vetrification, the vitrified samples were stored in MVE 120L 
vapour phase LN2 vessel (to maintain -180 c temp) [Figure11] for 1 night and was thawed 
after a night.  The thawing process is carried out by following the procedure in section 3.4, 
and the cells were counted as in section 3.5. Approximately, 1.3x10
7
cells/ml was viable, 
which is 72% viability (figure8). 
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Figure10: Trypan blue assay using haemocytometer under carl zeiss phase contrast 
microscope. 
 
Figure11: MVE 120L vapour phase LN2 vessel (to maintain -180 c temp) 
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4.3. Comparison 
 
vitrification technique 
 
Viability 
 
plunging method 
 
67% 
 
dispersed droplets by N2 gas 
  
72% 
 
 
Table3: comparison between the two vitrification methods. 
 
 
From the result shown in Table3, we can conclude that viability can be increased by the new 
method. 
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5.  CONCLUSION 
 
In summary, an effective way of vetrification for the cryopreservation of MNCs using 
Nitrogen gas vapour to create small droplets is introduced. The N2 gas also helped in 
precooling of the cells sample. And the most challenging part is that, it can be carried out in 
large scale in compare to the use of straw. 
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